31% increase in branded cannabis net revenue1 to $10.0 million from $7.6 million in the prior year#12 ranking for market share in core markets2 for Q1...
TORONTO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on August 11...
TORONTO, June 28, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it...
151% increase in branded cannabis net revenue1 to $36.8 million in 15-month fiscal year 2022 ended March 31, 2022 (new fiscal year end) from $14.6 million...
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on June 28,...
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it...
TORONTO, June 22, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is postponing the announcement...
Following final tabulation, Debentureholders pass Extraordinary Resolution approving Debenture AmendmentsCanceling Debentureholder meeting previously...
Debentureholders have executed sufficient consents and proxies to approve Debenture Amendments TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Aleafia Health...
Debentureholders representing approximately 61.4% of the Convertible Debentures outstanding have entered into Support Agreements1, including each member of...